Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE

NCT04505774 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

3591

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

DRUG: theraputic heparin
DRUG: prophylactic heparin
DRUG: P2Y12
DRUG: Crizanlizumab Injection
DRUG: SGLT2 inhibitor

Sponsor

Matthew Neal MD

Collaborators

[object Object]